vs

Side-by-side financial comparison of Absci Corp (ABSI) and Clearwater Paper Corp (CLW). Click either name above to swap in a different company.

Absci Corp is the larger business by last-quarter revenue ($650.0K vs $360.3K, roughly 1.8× Clearwater Paper Corp). Clearwater Paper Corp runs the higher net margin — -3.6% vs -4548.0%, a 4544.4% gap on every dollar of revenue. On growth, Absci Corp posted the faster year-over-year revenue change (-2.3% vs -4.7%). Over the past eight quarters, Absci Corp's revenue compounded faster (-6.5% CAGR vs -96.8%).

Absci Corp is a synthetic biology and AI-powered biotech firm focused on advancing next-generation biologic drug discovery and development. It delivers integrated protein engineering solutions to pharmaceutical and biopharmaceutical partners, enabling faster creation of novel antibodies, therapeutic proteins and other complex biologic candidates to address unmet global medical needs.

Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.

ABSI vs CLW — Head-to-Head

Bigger by revenue
ABSI
ABSI
1.8× larger
ABSI
$650.0K
$360.3K
CLW
Growing faster (revenue YoY)
ABSI
ABSI
+2.5% gap
ABSI
-2.3%
-4.7%
CLW
Higher net margin
CLW
CLW
4544.4% more per $
CLW
-3.6%
-4548.0%
ABSI
Faster 2-yr revenue CAGR
ABSI
ABSI
Annualised
ABSI
-6.5%
-96.8%
CLW

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ABSI
ABSI
CLW
CLW
Revenue
$650.0K
$360.3K
Net Profit
$-29.6M
$-12.8K
Gross Margin
-0.2%
Operating Margin
-4775.5%
Net Margin
-4548.0%
-3.6%
Revenue YoY
-2.3%
-4.7%
Net Profit YoY
-2.0%
-103.2%
EPS (diluted)
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABSI
ABSI
CLW
CLW
Q1 26
$360.3K
Q4 25
$650.0K
$386.4M
Q3 25
$399.0M
Q2 25
$593.0K
$391.8M
Q1 25
$1.2M
$378.2M
Q4 24
$665.0K
$387.1M
Q3 24
$1.7M
$393.3M
Q2 24
$1.3M
$344.4M
Net Profit
ABSI
ABSI
CLW
CLW
Q1 26
$-12.8K
Q4 25
$-29.6M
$38.3M
Q3 25
$-53.3M
Q2 25
$-30.6M
$2.7M
Q1 25
$-26.3M
$-6.3M
Q4 24
$-29.0M
$199.1M
Q3 24
$-27.4M
$5.8M
Q2 24
$-24.8M
$-25.8M
Gross Margin
ABSI
ABSI
CLW
CLW
Q1 26
-0.2%
Q4 25
4.5%
Q3 25
4.7%
Q2 25
11.0%
Q1 25
9.7%
Q4 24
3.8%
Q3 24
7.7%
Q2 24
-0.6%
Operating Margin
ABSI
ABSI
CLW
CLW
Q1 26
Q4 25
-4775.5%
1.9%
Q3 25
-13.9%
Q2 25
-5293.9%
2.5%
Q1 25
-2351.9%
-1.1%
Q4 24
-4477.3%
-4.0%
Q3 24
-1698.7%
-0.3%
Q2 24
-2104.0%
-13.6%
Net Margin
ABSI
ABSI
CLW
CLW
Q1 26
-3.6%
Q4 25
-4548.0%
9.9%
Q3 25
-13.4%
Q2 25
-5155.0%
0.7%
Q1 25
-2234.6%
-1.7%
Q4 24
-4358.3%
51.4%
Q3 24
-1610.7%
1.5%
Q2 24
-1948.8%
-7.5%
EPS (diluted)
ABSI
ABSI
CLW
CLW
Q1 26
Q4 25
$-0.19
$2.36
Q3 25
$-3.30
Q2 25
$-0.24
$0.17
Q1 25
$-0.21
$-0.38
Q4 24
$-0.26
$11.87
Q3 24
$-0.24
$0.35
Q2 24
$-0.22
$-1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABSI
ABSI
CLW
CLW
Cash + ST InvestmentsLiquidity on hand
$144.3M
$36.5M
Total DebtLower is stronger
$361.1M
Stockholders' EquityBook value
$189.4M
$813.8M
Total Assets
$216.3M
$1.6B
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABSI
ABSI
CLW
CLW
Q1 26
$36.5M
Q4 25
$144.3M
$30.7M
Q3 25
$34.4M
Q2 25
$38.0M
$46.7M
Q1 25
$47.0M
$44.0M
Q4 24
$112.4M
$79.6M
Q3 24
$38.2M
$35.5M
Q2 24
$42.9M
$39.6M
Total Debt
ABSI
ABSI
CLW
CLW
Q1 26
$361.1M
Q4 25
$346.8M
Q3 25
$337.0M
Q2 25
$330.1M
Q1 25
Q4 24
$4.0M
$283.4M
Q3 24
$1.2B
Q2 24
$1.1B
Stockholders' Equity
ABSI
ABSI
CLW
CLW
Q1 26
$813.8M
Q4 25
$189.4M
$825.3M
Q3 25
$783.0M
Q2 25
$173.4M
$836.8M
Q1 25
$198.8M
$836.6M
Q4 24
$179.1M
$854.6M
Q3 24
$201.3M
$664.6M
Q2 24
$221.5M
$658.6M
Total Assets
ABSI
ABSI
CLW
CLW
Q1 26
$1.6B
Q4 25
$216.3M
$1.6B
Q3 25
$1.6B
Q2 25
$209.9M
$1.6B
Q1 25
$232.4M
$1.6B
Q4 24
$213.6M
$1.7B
Q3 24
$235.2M
$2.5B
Q2 24
$255.5M
$2.5B
Debt / Equity
ABSI
ABSI
CLW
CLW
Q1 26
0.44×
Q4 25
0.42×
Q3 25
0.43×
Q2 25
0.39×
Q1 25
Q4 24
0.02×
0.33×
Q3 24
1.73×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABSI
ABSI
CLW
CLW
Operating Cash FlowLast quarter
$-29.2M
Free Cash FlowOCF − Capex
$-29.3M
FCF MarginFCF / Revenue
-4505.4%
Capex IntensityCapex / Revenue
15.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-85.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABSI
ABSI
CLW
CLW
Q1 26
Q4 25
$-29.2M
$5.0M
Q3 25
$34.0M
Q2 25
$-16.9M
$-28.2M
Q1 25
$-21.8M
$1.5M
Q4 24
$-17.0M
$-35.1M
Q3 24
$-20.7M
$16.2M
Q2 24
$-16.8M
$21.1M
Free Cash Flow
ABSI
ABSI
CLW
CLW
Q1 26
Q4 25
$-29.3M
$-9.9M
Q3 25
$15.7M
Q2 25
$-17.1M
$-51.1M
Q1 25
$-21.9M
$-31.2M
Q4 24
$-17.0M
$-68.1M
Q3 24
$-20.8M
$-30.8M
Q2 24
$-17.2M
$3.0M
FCF Margin
ABSI
ABSI
CLW
CLW
Q1 26
Q4 25
-4505.4%
-2.6%
Q3 25
3.9%
Q2 25
-2883.0%
-13.0%
Q1 25
-1854.5%
-8.2%
Q4 24
-2554.4%
-17.6%
Q3 24
-1221.6%
-7.8%
Q2 24
-1352.4%
0.9%
Capex Intensity
ABSI
ABSI
CLW
CLW
Q1 26
Q4 25
15.8%
3.9%
Q3 25
4.6%
Q2 25
37.6%
5.8%
Q1 25
2.1%
8.6%
Q4 24
3.5%
8.5%
Q3 24
2.8%
12.0%
Q2 24
26.2%
5.3%
Cash Conversion
ABSI
ABSI
CLW
CLW
Q1 26
Q4 25
0.13×
Q3 25
Q2 25
-10.44×
Q1 25
Q4 24
-0.18×
Q3 24
2.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons